Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Restructuring Costs (2025)

Silence Therapeutics' Restructuring Costs history spans 1 years, with the latest figure at $1.3 million for Q2 2025.

  • For Q2 2025, Restructuring Costs changed N/A year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, changed N/A, while the annual FY2025 figure was $1.3 million, N/A changed from the prior year.
  • Restructuring Costs for Q2 2025 was $1.3 million at Silence Therapeutics.
  • Across five years, Restructuring Costs topped out at $1.3 million in Q2 2025 and bottomed at $1.3 million in Q2 2025.